Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing
Charlene Waryah, Colette Moses, Mahira Arooj, et al.
Methods in molecular biology (2018), pp. 19-63
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Gene Editing and Systems Biology Tools for Pesticide Bioremediation: A Review
Shweta Jaiswal, Dileep Kumar Singh, Pratyoosh Shukla
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 169
Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective
Debin Zhang, Amjad Hussain, Hakim Manghwar, et al.
Plant Biotechnology Journal (2020) Vol. 18, Iss. 8, pp. 1651-1669
Open Access | Times Cited: 160
The sound of silence: Transgene silencing in mammalian cell engineering
Alan Cabrera, Hailey I. Edelstein, Fokion Glykofrydis, et al.
Cell Systems (2022) Vol. 13, Iss. 12, pp. 950-973
Open Access | Times Cited: 97
Microbial Remediation: A Promising Tool for Reclamation of Contaminated Sites with Special Emphasis on Heavy Metal and Pesticide Pollution: A Review
Najeebul Tarfeen, Khair Ul Nisa, Burhan Hamid, et al.
Processes (2022) Vol. 10, Iss. 7, pp. 1358-1358
Open Access | Times Cited: 78
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
A precision environmental health approach to prevention of human disease
Andrea Baccarelli, Dana C. Dolinoy, Cheryl L. Walker
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
DNA methylation in mammalian development and disease
Zachary D. Smith, Sara Hetzel, Alexander Meissner
Nature Reviews Genetics (2024)
Open Access | Times Cited: 35
The influence of eukaryotic chromatin state on CRISPR–Cas9 editing efficiencies
Sebald A. N. Verkuijl, Marianne G. Rots
Current Opinion in Biotechnology (2018) Vol. 55, pp. 68-73
Open Access | Times Cited: 120
From OPC to Oligodendrocyte: An Epigenetic Journey
Assia Tiane, Melissa Schepers, Ben Rombaut, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1236-1236
Open Access | Times Cited: 97
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
Colette Moses, Fiona Nugent, Charlene Waryah, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 14, pp. 287-300
Open Access | Times Cited: 95
Cancer's epigenetic drugs: where are they in the cancer medicines?
Sorayya Ghasemi
The Pharmacogenomics Journal (2019) Vol. 20, Iss. 3, pp. 367-379
Closed Access | Times Cited: 85
Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review
Farha Ramzan, Mark H. Vickers, Richard Mithen
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 5047-5047
Open Access | Times Cited: 59
Compact zinc finger base editors that edit mitochondrial or nuclear DNA in vitro and in vivo
Julian C. W. Willis, Pedro Silva-Pinheiro, Lily Widdup, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges
Jun Ueda, Taiga Yamazaki, Hiroshi Funakoshi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4778-4778
Open Access | Times Cited: 34
Hallmarks of cancer: The CRISPR generation
Colette Moses, Benjamín Garcia-Bloj, Alan R. Harvey, et al.
European Journal of Cancer (2018) Vol. 93, pp. 10-18
Open Access | Times Cited: 77
The role of environmental exposures and the epigenome in health and disease
Bambarendage P. U. Perera, Christopher Faulk, Laurie K. Svoboda, et al.
Environmental and Molecular Mutagenesis (2019) Vol. 61, Iss. 1, pp. 176-192
Open Access | Times Cited: 71
Development and application of CRISPR/Cas9 technologies in genomic editing
Cui Zhang, Renfu Quan, Jinfu Wang
Human Molecular Genetics (2018) Vol. 27, Iss. R2, pp. R79-R88
Open Access | Times Cited: 67
Epigenome engineering: new technologies for precision medicine
Agustin Sgro, Pilar Blancafort
Nucleic Acids Research (2020) Vol. 48, Iss. 22, pp. 12453-12482
Open Access | Times Cited: 54
Prokaryotic Argonaute Proteins as a Tool for Biotechnology
Ekaterina Kropocheva, Lidiya Lisitskaya, Aleksei Agapov, et al.
Molecular Biology (2022) Vol. 56, Iss. 6, pp. 854-873
Open Access | Times Cited: 29
Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics
Ana P. Teixeira, Martin Fussenegger
Advanced Science (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 21
The design of synthetic gene circuits in plants: new components, old challenges
Marta Vázquez‐Vilar, Sara Selma, Diego Orzáez
Journal of Experimental Botany (2023) Vol. 74, Iss. 13, pp. 3791-3805
Open Access | Times Cited: 19
CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications
Andrew M. Subica
American Journal of Public Health (2023) Vol. 113, Iss. 8, pp. 874-882
Open Access | Times Cited: 19
Linking Prenatal Environmental Exposures to Lifetime Health with Epigenome-Wide Association Studies: State-of-the-Science Review and Future Recommendations
Kelly M. Bakulski, Freida Blostein, Stephanie J. London
Environmental Health Perspectives (2023) Vol. 131, Iss. 12
Open Access | Times Cited: 18
Unraveling Microbes as Potential Proxies for Remediation of Heavy Metal and Pesticide Contamination: A State-of-the Art Review
Sabreena, Shahnawaz Hassan, Vineet Kumar, et al.
International Journal of Environmental Research (2023) Vol. 17, Iss. 5
Closed Access | Times Cited: 17
Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia
Joel Gottesfeld
Neurotherapeutics (2019) Vol. 16, Iss. 4, pp. 1032-1049
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top